Common Contracts
4 similar Underwriting Agreement contracts by Pliant Therapeutics, Inc., dLocal LTD, Owl Rock Capital Corp
Pliant Therapeutics, Inc. 8,333,334 Shares Common Stock (par value $0.0001 per share) Underwriting AgreementUnderwriting Agreement • January 25th, 2023 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • New York
Pliant Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company set forth in Schedule I hereto (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Common Stock set forth in Schedule I hereto (the “Option Securities”; the Option Securities, collectively with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule II other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the
Pliant Therapeutics, Inc. 10,810,811 Shares Common Stock ($0.0001 par value) Underwriting AgreementUnderwriting Agreement • July 14th, 2022 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • New York
Pliant Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of common stock, $0.0001 par value (“Common Stock”) of the Company set forth in Schedule I hereto (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to the number of additional shares of Common Stock set forth in Schedule I hereto (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule II other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plu
DLocal Limited [●] Class A Common Shares Underwriting AgreementUnderwriting Agreement • May 20th, 2021 • dLocal LTD • Services-business services, nec • New York
DLocal Limited, a Cayman Islands exempted company incorporated with limited liability (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] Class A common shares, par value $0.002 per share (the “Class A Common Shares”), of the Company, and certain shareholders of the Company named in Section 1 of Schedule 2 hereto (the “Group 1 Selling Shareholders”) and certain shareholders of the Company named in Section 2 of Schedule 2 hereto (the “Group 2 Selling Shareholders” and, together with the Group 1 Selling Shareholders, the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [●] Class A Common Shares (collectively, the “Underwritten Shares”). In addition, the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [●] Class A Common Shares (collectively, the “Option S
OWL ROCK CAPITAL CORPORATION [●] SHARES OF COMMON STOCK Underwriting AgreementUnderwriting Agreement • June 25th, 2019 • Owl Rock Capital Corp • New York
Owl Rock Capital Corporation, a Maryland corporation (the “Company”), proposes subject to the terms and conditions stated herein, to issue and sell to the several Underwriters named in Schedule 1 hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 11 hereof), for whom you are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the
